AGA Abstracts250 - Unchanged Infliximab Serum Concentrations After Switching from the Originator Infliximab to the Biosimilar CT-P13 in Patients with Quiescent Crohn's Disease: A Prospective Study
References (0)
Cited by (0)
Copyright © 2017 The AGA Institute. Published by Elsevier Inc. All rights reserved.